Comments on Reporting Threshold for Institutional Investment Managers

Comments have been received from individuals and entities using a variety of Letter Types:

Comment
A: 86
B: 3

Filter comments

Date Received
Date Letter Type Commenter Name
Public Comment Nathan B.
Public Comment Brandon Smith
Public Comment Dave Cazza
Public Comment N. Abanes
Public Comment Hussam Eldin Ahmed Elsheikh
Public Comment John Eidmann
Public Comment Ken H.
Public Comment David Kwon
Public Comment Binoy Biju
Public Comment Varun Yadagiri
Public Comment Lynne Thorp
Public Comment Eugene Moh
Public Comment William Peysson
Public Comment David J. Smetana, Chief Financial Officer, Mack-Cali Realty Corporation
Public Comment Michael Stubblefield, President and Chief Executive Officer, Avantor, Inc.
Public Comment Anonymous
Public Comment Branislav Jovan
Public Comment Jaculine Mitchell, Eaglepointwest
Public Comment Richard Zhao
Public Comment N. S.
Public Comment Jerome Marcoux, Financial Advisor
Public Comment L. A. Forbes
Public Comment Arup K. Dolui
Meeting with SEC Officials Memorandum from the Office of Commissioner Hester M. Peirce regarding an October 8, 2020 meeting with representatives of the Biotechnology Innovation Organization
Public Comment John S. Hess, Jr., EVP, Deputy General Counsel, United Therapeutics Corp.
Public Comment Greg Gilles
Public Comment Bala Vishwa
Meeting with SEC Officials Memorandum from the Office of the Chairman regarding an October 1, 2020 meeting with representatives Representatives of the Biotechnology Innovation Organization
Public Comment Robert Rutkowski
Public Comment Stephen Deane, Sr. Director, Capital Markets Policy, CFA Institute and James C. Allen, Head, Capital Markets Policy, Americas, CFA Institute

Last Reviewed or Updated: Dec. 18, 2025

File Number
S7-08-20
Release Number
34-89290
Related Materials
How to submit comments